TrialFrontiers in endocrinology2025

Safety and efficacy of fixed-dose combination of dapagliflozin and saxagliptin in patients with type 2 diabetes mellitus - a phase 4 study in India.

S K Wangnoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.